{"id":19035,"date":"2022-01-14T12:11:25","date_gmt":"2022-01-14T11:11:25","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/e015-genetica-de-poblaciones-en-biomedicina-genpob\/"},"modified":"2026-03-20T10:07:06","modified_gmt":"2026-03-20T09:07:06","slug":"e015-genetica-de-poblaciones-en-biomedicina-genpob","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/en\/grupo-de-investigacion\/e015-genetica-de-poblaciones-en-biomedicina-genpob\/","title":{"rendered":"C047 – Population Genetics in Biomedicine (GenPoB)"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||||false|false” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.16″ _module_preset=”default” width=”100%” custom_padding=”0px||||false|false” locked=”off” collapsed=”on” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” global_colors_info=”{}”]AREA: INFECTOLOGY, INFLAMMATION AND VACCINES<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ _module_preset=”default” width=”100%” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.idisantiago.es\/wp-content\/uploads\/2021\/11\/grupo_investigacion.jpg” title_text=”Corporate portrait of office workers and employees” disabled_on=”on|on|on” _builder_version=”4.16″ _module_preset=”default” disabled=”on” global_colors_info=”{}”][\/et_pb_image][et_pb_toggle title=”Objectives and lines of research” disabled_on=”on|on|on” admin_label=”Objetivos y l\u00edneas de investigaci\u00f3n” _builder_version=”4.16″ _module_preset=”default” body_font=”|300|||||||” disabled=”on” global_colors_info=”{}”]<\/p>\n

Objetivos<\/h3>\n

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.<\/p>\n

L\u00edneas de investigaci\u00f3n<\/h3>\n

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.<\/p>\n

 <\/p>\n

[\/et_pb_toggle][et_pb_toggle title=”Research team” admin_label=”Equipo investigador” _builder_version=”4.21.0″ _module_preset=”default” body_font=”|300|||||||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Leader<\/strong>
Salas Ellacuriaga, Antonio<\/p>\n

Coleader<\/strong>
G\u00f3mez Carballa, Alberto<\/p>\n\n\n\n
Members<\/strong>
Aldonza Torres, Marta
\u00c1lvarez Iglesias, Vanesa
Barral Arca, Ruth
Camino Mera, Alba
Castelo Mart\u00ednez, L\u00faa
Curros Novo, Carmen
Dacosta Urbieta, Ana Isabel
Dominik Nowak, Wiktor
Fern\u00e1ndez Garc\u00eda, Jos\u00e9 Manuel
Ferreir\u00f3s Vidal, Isabel
Gago Ageitos, Ana Mar\u00eda
Gamborino Caram\u00e9s, Mar\u00eda Elena
Garc\u00eda Curr\u00e1s, Julia
Mallah, Narmeen
Mallah, Nour El Zahraa
Montoto Louzao, Juli\u00e1n
Navarro Ram\u00f3n, Laura<\/td>\n		\n

Pardo Seco, Jacobo Jos\u00e9
Pischedda, Sara
Rego Lijo, Isabel
Regueiro Casuso, Patricia
Rey V\u00e1zquez, Sara
Rodr\u00edguez Calvo, Mar\u00eda Sol
Taboada Puga, Miriam
Visos Varela, Irene
Viz Lasheras, Sandra<\/p>\n

External Collaborator Staff<\/strong>
\u00c1lvarez Mart\u00edn, Adri\u00e1n
Agredano Fern\u00e1ndez, Sergio
Carrero Caram\u00e9s, Ux\u00eda
Castro Gonz\u00e1lez-Guirado, Paula
Cavenaghi, Andrea
Egeland, Thore
Mart\u00ednez, Cadenas, Conrado
Rivera Garc\u00eda, Isabela
Toscanini, Ulises
Varela M\u00edguez, Sara
Villar Mu\u00ed\u00f1os, Nuria<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/et_pb_toggle][et_pb_toggle title=”Projects” disabled_on=”on|on|on” admin_label=”Proyectos (cambiar s\u00f3 codigo IDIS)” _builder_version=”4.16″ _module_preset=”default” body_font=”|300|||||||” disabled=”on” locked=”off” global_colors_info=”{}”]<\/p>\nBI-BACVIR: Detecci\u00f3n de Biomarcadores Bacterianos y V\u00edricos a pie de cama<\/strong>
Project code: PRIS 3. BI-BACVIR
Funding entity: Xunta de Galicia
Duration: 2019
Amount: 19967 EUR
Principal investigator: Antonio Salas Ellacuriaga<\/a> Federico Martin\u00f3n Torres
<\/p>\n

Childhood Life Threatening Infectious Diseases Study (EUCLIDS)<\/strong>
Project code: 279185
Funding entity: Uni\u00f3n Europea
Duration: 2011-2015
Principal investigator: Federico Martin\u00f3n Torres<\/a> Antonio Salas Ellacuriaga
<\/p>\n

DIAVIR: Desarrollo y Validaci\u00f3n Cl\u00ednica de una Herramienta Molecular para el Diagn\u00f3stico de Enfermedades Virales en Sangre y Saliva basado en la Detecci\u00f3n de Biomarcadores Transcript\u00f3micos<\/strong>
Project code: DTS19\/00049
Funding entity: Instituto de Salud Carlos III
Duration: 2020-2021
Amount: 94600 EUR
Principal investigator: Antonio Salas Ellacuriaga<\/a>
<\/p>\n

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management across the European Union (PERFORM)<\/strong>
Project code: EC-GA number: 668303
Funding entity: Comisi\u00f3n Europea \/ European Commission
Duration: 2016-2020
Principal investigator: Federico Martin\u00f3n Torres<\/a> Antonio Salas Ellacuriaga
<\/p>\n

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management across the European Union (PERFORM)<\/strong>
Project code: EC-GA number: 668303
Funding entity: Comisi\u00f3n Europea \/ European Commission
Duration: 2016-2020
Principal investigator: <\/a> Antonio Salas Ellacuriaga
<\/p>\n

ReSVi-omics: hacia una medicina personalizada en la infecci\u00f3n por virus respiratorio sincitial a trav\u00e9s del uso de una aproximaci\u00f3n \u2018-omica\u2019<\/strong>
Project code: PI19\/01039
Funding entity: Instituto de Salud Carlos III
Duration: 2020-2023
Amount: 122815 EUR
Principal investigator: Antonio Salas Ellacuriaga<\/a>
<\/p>\n

\n

[\/et_pb_toggle][et_pb_toggle title=”Publications” disabled_on=”on|on|on” admin_label=”Publicaciones” _builder_version=”4.16″ _module_preset=”default” body_font=”|300|||||||” disabled=”on” global_colors_info=”{}”]<\/p>\n